Check out our track record of previous Healthcare Transactions.
LIFE SCIENCE M&A
Life Sciences Investment Banking
Hyde Park Capital partners with leaders in life science tools, diagnostics, and laboratory services to drive capital and growth. We understand pressures from shrinking reimbursements, payer friction, and adoption hurdles that slow scale. Our approach positions companies to showcase utilization, recurring revenue, and defensible niches that investors reward with premium valuations.
Our diligence looks beyond revenue to assess backlog, payer mix, automation adoption, and reimbursement risk. We design processes that highlight readiness, clinical milestones, and category strengths in oncology, cardiometabolic, women’s health, and precision diagnostics. From structuring deals to managing diligence, we accelerate closings, improve terms, and position clients for durable growth.
Life Science Tools
Tool providers face adoption hurdles, heavy R&D costs, and pressure from shrinking research budgets. Hyde Park Capital positions platforms with defensible IP, sticky consumables, and scalable technology. That foundation accelerates adoption, builds recurring revenue, and supports premium valuations.
Explore Life Science Tools Advisory
Clinical Laboratory Services
Labs are squeezed by shrinking reimbursements, payer denials, and mounting compliance expenses. We highlight payer contracts, operational efficiency, and volume strength to make platforms more attractive to acquirers. The result is faster cash conversion and valuations tied to recurring revenue streams.
Explore Clinical Lab Services Advisory
Specialized Diagnostic Services
Lab Developed Tests (LDTs) and niche diagnostics struggle with high R&D spend, regulatory hurdles, and uncertain adoption timelines. Hyde Park Capital helps secure payer alignment, formalize health-system partnerships, and scale efficiently. This accelerates adoption and supports valuations tied to utilization strength.
Learn More about Specialized Diagnostic Services
Molecular Biology and Genetic Testing
Shifting CPT codes, evidence burdens, and payer pushback slow reimbursement in genetic testing. We secure payer coverage, expand assay menus, and emphasize clinical adoption curves. Buyers see stability and growth, translating into premium valuations for scalable platforms.
Hematology and Clinical Chemistry
Routine testing faces intense competition, commoditization, and margin erosion. Hyde Park Capital identifies efficiencies and recurring test demand to strengthen platform value. That combination drives stable cash flow and premium valuations even in competitive markets.
Clinical Microbiology and Infectious Disease Testing
Microbiology providers deal with compliance demands, supply chain costs, and complex reimbursement. We highlight payer coverage, clinical necessity, and scale to reassure investors. The outcome is stronger contract visibility and valuations that reward revenue durability.
Cytopathology
Cytology groups face declining rates and rising competition from molecular assays. Hyde Park Capital positions operators by emphasizing steady referral networks, sample consistency, and efficient workflows. This translates into durable revenue and stronger cash conversion.
Blood Banking and Transfusion Medicine
Blood centers face rising costs, donor shortages, and pressure from hospital contracts. We highlight recurring demand, efficient collection operations, and defensible hospital relationships. Investors recognize stability, creating predictable cash flow and long-term value.
Anatomic and Digital Pathology
Pathology groups contend with falling per-test reimbursement and the steep cost of digital adoption. Hyde Park Capital helps scale operations, formalize referral pathways, and demonstrate recurring demand. This creates predictable sample flow, stronger margins, and higher deal multiples.
Lab Technology, Automation, and AI
Automation and AI platforms face slow adoption cycles, integration costs, and buyer skepticism. We demonstrate ROI, highlight sticky revenue models, and position platforms for scale. The result is faster adoption, stronger margins, and technology-driven valuations.
Consumables
Consumable suppliers compete on price, face margin pressure, and rely on lab utilization trends. Hyde Park Capital emphasizes sticky contracts, recurring demand, and margin defensibility. That stability creates predictable revenue and premium valuations.
Expertise in Substance Abuse Testing
Substance abuse testing labs face volatile volumes, payer pressure on pricing, and regulatory scrutiny that challenge stability. Hyde Park Capital supports operators in building scalable platforms with durable contracts, expanding service lines through targeted acquisitions, and strengthening compliance frameworks. These strategies deliver steadier utilization, recurring revenue, and valuations that reward operational resilience and market relevance.
HEALTHCARE INVESTMENT BANKING TRANSACTIONS
Recent Healthcare Transactions
Loading transactions...
SENIOR HEALTHCARE INVESTMENT BANKERS
Meet HPC’s Experts
Meet our highly specialized team of healthcare investment bankers.
HEALTHCARE INDUSTRY REPORTS
See our latest Healthcare Industry Reports
Stay informed with our latest insights.
Loading Industry Reports...
Stay Updated with M&A Reports
Sign up to receive the latest insights and updates on M&A activities in the Healthcare industry.
HEALTHCARE INVESTMENT BANKING SECTORS
Supporting Growth Across All of the Healthcare Sectors
Hyde Park Capital partners with healthcare companies to unlock growth, attract strategic capital, and complete transactions that strengthen market position. We bring decades of sector expertise to identify opportunities and deliver results that build lasting enterprise value.
Our track record spans transactions across key healthcare sectors, including:
- Healthcare Services
- Healthcare Technology
- Medical Devices and Diagnostics
- Pharmaceuticals and Pharma Services
- Life Science Tools, Diagnostics, and Laboratory Services
Healthcare Services
- Ambulatory Surgery Centers
- Behavioral Health
- Dental Practices and Dental Health
- Healthcare Consulting
- Healthcare Staffing and Workforce Management
- Home Healthcare and Hospice
- Medical Distribution
- Medical Transportation
- Payor and Employer Services
- Physician Practice Management
- Primary Care and Multi-Specialty Clinics
- Retail Healthcare
Healthcare Technology
- Benefits Technology Stack
- Cost Containment / Payment Integrity
- Electronic Health Records and Interoperability
- Patient Engagement
- Provider Workflow Automation
- Remote Patient Monitoring / Virtual Care / Telehealth
- Revenue Cycle Management
- Value-Based Care Enablement
Medical Device and Diagnostics
- Biomaterials / Regenerative Medicine
- Digital Pathology
- Durable Medical Equipment (DME)
- In Vitro
- Medical Imaging
- Medical Supplies
- Monitoring and Wearables
- Point-of-Care
- Robotics
- Sleep Tools
- Surgical Tools
Pharmaceuticals and Pharma Services
- Discovery and Pre-clinical Development
- Contract Development and Manufacturing (CDMO/CMO)
- Contract Research Organizations (CRO)
- Drug Delivery and Packaging
- Pharma Consulting and Commercialization
- Pharmaceutical Safety and Risk Management
- Pharma Tech
- Pharmaceutical Contract Management Consulting (CMC)
- Distribution and Patient Access
- Pharmaceutical Supply Chain
- Clinical Services, Supplies, and Testing
Life Science Tools, Diagnostics, and Laboratory Services
- Life Science Tools
- Clinical Laboratory Services
- Anatomic and Digital Pathology
- Molecular Biology and Genetic Testing
- Hematology and Clinical Chemistry
- Clinical Microbiology and Infectious Disease Testing
- Cytopathology
- Blood Banking and Transfusion Medicine
- Specialized Diagnostic Services
- Lab Technology, Automation, and AI
- Consumables
Schedule Your Private Consultation
Connect with our senior investment banking team to explore the next step for your business.
Let's Talk Details